摘要
溶栓治疗和神经保护治疗是缺血性脑卒中的两大药物干预策略 ,其中广义的神经保护治疗包括神经保护和神经修复两种方法 ,而目前存在的中西医结合缺血性脑卒中的药物干预策略可能也存在多层次、分阶段干预的特点 ,体现了祖国医学“同病异治”的原则 ,我们认为现有的缺血脑保护方法主要针对缺血性脑卒中的不同发展阶段 ,而神经修复的研究 ,尤其是中医药促进神经干细胞再生的研究 ,可能蕴涵着巨大的发展潜力和无限商机。
Streptokine and neuroprotection are 2 big drug intervention strategies to treat ischemic cerebral apoplexy.Among which the neuroprotection in broad meaning contains 2 methods of protection and restoration,and the present drug intervention strategy of treating ischemic cerebral apoplexy with combination of TCM and western medicine may have the characteristics of multi-layer by stages,embodying the principle of “treating the same disease with different methods”in Chinese medicine.In our view,the existent cerebral protection of ischemia points mainly to the different stages of ischemic cerebral apoplexy,and the research of neurorestoration,especially of the TCM promoting regeneration of nerve trunk cells,may contain large developing potential and limitless commercial opportunity.
出处
《浙江中医学院学报》
2004年第6期4-6,共3页
Journal of Zhejiang College of Traditional Chinese Medicine
关键词
缺血性脑卒中
缺血级联反应
同病异治
神经保护
神经修复
中医药疗法
ishemic cerebral apoplexy,cascade of damage,treating the same disease with different methods,neuroprotection,neurorestoration